SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading Update

26 Apr 2019 07:00

RNS Number : 1677X
Rotork PLC
26 April 2019
 

Rotork Plc

Trading update

Rotork plc ("Rotork"), the global flow control and instrumentation company, issues the following trading update covering the first quarter period from 1 January to 31 March 2019 ahead of its Annual General Meeting to be held today.

The first quarter saw a gradual improvement in overall levels of activity from the fourth quarter. Order intake (on an organic constant currency basis, "OCC") was modestly ahead of the fourth quarter, though as anticipated was down on the 2018 comparator period which included several large greenfield orders, principally from the Downstream Oil & Gas end user market. 

Our Growth Acceleration Programme continues on track with progress across all four pillars. Our lean/continuous improvement rollout has started encouragingly. Our phased transition to a market segment orientation commences in the second quarter with China, Japan and South Korea. 

Rotork continues to be highly cash generative with a strong balance sheet and net cash of £46.5m at 31 March 2019 (£43.6m at 31 December 2018).

Whilst we remain mindful of macroeconomic uncertainty we continue to expect to deliver modest sales growth on an OCC basis in 2019, with lower year on year sales in the first half reflecting the strong comparator period, and full year margins to show progress on 2018.

Rotork will publish 2019 half-year results on Tuesday 6 August 2019.

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The figures quoted in this announcement are unaudited and are subject to the review process that will be undertaken for the H1 19 results announcement. The person responsible for arranging for the release of this announcement on behalf of Rotork is Helen Barrett-Hague (Company Secretary).

 

Notes

1. OCC (organic constant currency) growth rates restate 2019 at 2018 exchange rates and remove the contributions from disposals made in 2018.

2. This announcement contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement, and Rotork undertakes no obligation to update these forward-looking statements. Nothing in this Trading Statement should be construed as a profit forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVTSVIEFIA
Date   Source Headline
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20262:19 pmRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 202612:00 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:13 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSAppointment of Joint Broker and Financial Adviser
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20269:42 amRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20269:43 amRNSTotal Voting Rights
22nd Dec 20253:00 pmRNSShare buyback programme
22nd Dec 20253:00 pmRNSShare buyback programme
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20253:17 pmRNSHolding(s) in Company
15th Dec 20257:18 amRNSTransaction in Own Shares
12th Dec 20254:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.